Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Celecoxib in Grand-Mal Epilepsy
NCT05637086Phase 2Recruiting
- Start
- Dec 2022
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline, celecoxib in epilepsy. Started Dec 2022; status: recruiting.
02
Drugs
pentoxifyllinecelecoxib
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05637086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637086.